Alpataz 250mg/31.25mg Injection
Marketer
Alpa Laboratories Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Alpataz 250mg/31.25mg Injection
Combiflox, a 250mg/31.25mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance. Consistent adherence to the prescribed schedule is vital; completing the entire course is crucial, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (skin rashes, pruritus, edema, dyspnea) require prompt emergency care. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, drowsiness or dizziness warrants abstention from driving. Adequate rest, nutrition, and hydration promote faster recovery. Monitoring via laboratory tests may be implemented to assess treatment response.
Primary Ingredients of Alpataz 250mg/31.25mg Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Alpataz 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Alpataz 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Alpataz 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Alpataz 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Alpataz 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam 250mg/31.25mg (Alpataz) injection unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antimicrobial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Alpataz 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Alpataz 250mg/31.25mg is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingCAUTION
The administration of Alpataz 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Alpataz 250mg/31.25mg can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Alpataz 250mg/31.25mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The 250mg/31.25mg Alpataz Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for the 250mg/31.25mg Alpataz Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Alpataz 250mg/31.25mg Injection :
Omit doses of Alpataz 250mg/31.25mg Injection only after physician consultation.
Facts to Know About Alpataz 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently